Certified by Founder Lodge
MiRXES
Singapore - ND
INVESTOR
1 Disclosed Funding Rounds $4,500,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
MiRXES is a Singapore-headquartered biotechnology company whose mission is to save lives through early, actionable, and personalized diagnoses across the care continuum.
We are Asia-center
Med247
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
PADO AI | $6,000,000 | (Mar 20, 2026)
Manifold Security | $8,000,000 | (Mar 19, 2026)
Beautiful.ai | $45,000,000 | (Mar 19, 2026)
Obin AI | $7,000,000 | (Mar 19, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)
